Medeiros I A, Santos M R V, Nascimento N M S, Duarte J C
Laboratório de Tecnologia Farmacêutica, Universidade Federal da Paraiba, João Pessoa, PB, Brazil.
Fitoterapia. 2006 Jan;77(1):19-27. doi: 10.1016/j.fitote.2005.06.003. Epub 2005 Oct 28.
The cardiovascular activity of the aqueous fraction of the hydroalcoholic extract of Sida cordifolia leaves (AFSC) was evaluated. In normotensive non-anaesthetized rats was observed that AFSC (5, 10, 20, 30 and 40 mg/kg, i.v.) induced hypotension (6 +/- 2%; 8 +/- 2%; 11 +/- 2%; 19 +/- 3% and 33 +/- 3%, respectively) and bradycardia (0.3 +/- 3%; 13 +/- 4%; 38 +/- 6%; 64 +/- 7% and 80 +/- 5%, respectively). Hypotensive response was completely abolished after atropine (2 mg/kg; i.v.) but potentialized after hexamethonium (20 mg/kg; i.v.) (12 +/- 2%; 21 +/- 5%; 28 +/- 3%; 32 +/- 2% and 32 +/- 3%, respectively), while bradycardic response was completely abolished after atropine (2 mg/kg; i.v.) and attenuated with hexamethonium (20 mg/kg; i.v.) (1 +/- 0.3%; 5 +/- 1%; 7 +/- 1%; 7 +/- 1% and 10 +/- 1%, respectively). In hexamethonium treated rats, L-NAME significantly attenuated the hypotensive response (9 +/- 2%; 14 +/- 1%; 16 +/- 1%; 16 +/- 2% and 22 +/- 3%, respectively). In normotensive anaesthetized and vagotomized rats, hypotensive and bradycardic responses were significantly attenuated (0.5 +/- 0.2%; 1 +/- 0.4%; 3 +/- 0.6%; 4 +/- 0.8% and 6 +/- 1%, respectively, n = 6, and 7 +/- 2%; 12 +/- 5%; 15 +/- 2%, 17 +/- 2% and 25 +/- 3%, respectively). The anaesthesia with sodium thiopental did not affect the AFSC-induced responses when compared with those induced in non-anaesthetized rats (data not showed). In conclusion, the results obtained so far show that AFSC produce hypotension and bradycardia, mainly due to a direct stimulation of the endothelial vascular muscarinic receptor and indirect cardiac muscarinic activation, respectively.
对黄花稔叶水醇提取物的水相部分(AFSC)的心血管活性进行了评估。在血压正常的未麻醉大鼠中观察到,AFSC(静脉注射,剂量为5、10、20、30和40毫克/千克)分别引起低血压(分别为6±2%;8±2%;11±2%;19±3%和33±3%)和心动过缓(分别为0.3±3%;13±4%;38±6%;64±7%和80±5%)。阿托品(静脉注射,剂量为2毫克/千克)后,降压反应完全消失,但六甲铵(静脉注射,剂量为20毫克/千克)后增强(分别为12±2%;21±5%;28±3%;32±2%和32±3%),而心动过缓反应在阿托品(静脉注射,剂量为2毫克/千克)后完全消失,六甲铵(静脉注射,剂量为20毫克/千克)使其减弱(分别为1±0.3%;5±1%;7±1%;7±1%和10±1%)。在六甲铵处理的大鼠中,L-NAME显著减弱了降压反应(分别为9±2%;14±1%;16±1%;16±2%和22±3%)。在血压正常的麻醉和迷走神经切断的大鼠中,降压和心动过缓反应显著减弱(分别为0.5±0.2%;1±0.4%;3±0.6%;4±0.8%和6±1%,n = 6,以及分别为7±2%;12±5%;15±2%,17±2%和25±3%)。与未麻醉大鼠相比,硫喷妥钠麻醉不影响AFSC诱导的反应(数据未显示)。总之,目前获得的结果表明,AFSC产生低血压和心动过缓,主要分别是由于直接刺激内皮血管毒蕈碱受体和间接激活心脏毒蕈碱受体。